氧化应激
血管生成
化学
子宫内膜异位症
活性氧
炎症
癌症研究
药理学
内化
细胞生物学
药物输送
体外
细胞凋亡
新生血管
抗氧化剂
肿瘤微环境
活性氮物种
信号转导
病变
平衡
氧化磷酸化
基质金属蛋白酶
体内
生物化学
作者
Jie Zhang,Haitao Zhang,Wei Liu,Yi Zhang,Wenjie Hou,Chi Chi
标识
DOI:10.1186/s12951-026-04560-6
摘要
Endometriosis progression is driven by oxidative stress and excessive angiogenesis within an inflammatory microenvironment. To overcome these challenges, we designed ROS/pH dual-responsive Alpelisib-loaded nanoparticles (Alp@TAT-AT7-NPs) functionalized with an anti-NRP1 peptide for targeted therapy. The nanoparticles exhibited superior stability, responsive drug release, and selective internalization by NRP1-overexpressing endothelial cells. In vitro results showed efficient inhibition of NRP1 and downstream PI3K/AKT signaling, along with decreased reactive oxygen species (ROS) and enhanced antioxidant enzyme activities. In an endometriosis rat model, treatment with Alp@TAT-AT7-NPs significantly reduced ectopic lesion burden and angiogenic markers (VEGF, CD34), while suppressing systemic inflammation and oxidative injury indicators such as IL-6, TNF-α, and MDA. Fluorescence imaging confirmed preferential accumulation of nanoparticles in CD31⁺ vascular regions. Mechanistic studies demonstrated that modulation of the Sema3A-NRP1-PI3K/AKT signaling axis restored redox homeostasis and inhibited pathological angiogenesis. These findings identify Alp@TAT-AT7-NPs as a synergistic nanoplatform that integrates microenvironment responsiveness with NRP1-targeted intervention, providing a promising therapeutic strategy for endometriosis.
科研通智能强力驱动
Strongly Powered by AbleSci AI